0001104659-23-111093.txt : 20231024
0001104659-23-111093.hdr.sgml : 20231024
20231024160638
ACCESSION NUMBER: 0001104659-23-111093
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231020
FILED AS OF DATE: 20231024
DATE AS OF CHANGE: 20231024
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rickard Kathleen A.
CENTRAL INDEX KEY: 0001836883
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38067
FILM NUMBER: 231342768
MAIL ADDRESS:
STREET 1: C/O VERONA PHARMA PLC
STREET 2: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2RE
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verona Pharma plc
CENTRAL INDEX KEY: 0001657312
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2RE
BUSINESS PHONE: 011-44-0-2032834200
MAIL ADDRESS:
STREET 1: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2RE
4
1
tm2329036-3_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-10-20
0
0001657312
Verona Pharma plc
VRNA
0001836883
Rickard Kathleen A.
3 MORE LONDON RIVERSIDE
LONDON
X0
SE1 2RE
UNITED KINGDOM
0
1
0
0
Chief Medical Officer
0
Ordinary Shares
2023-10-20
4
A
0
200000
0
A
3072528
D
Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
Represents an award of Restricted Share Units ("RSUs"), each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer. The RSUs vest over four years, with 50,000 RSUs vesting on November 1, 2024 and the balance vesting in 12 equal quarterly installments thereafter.
Consists of (i) 1,751,792 Ordinary Shares underlying RSUs (which are represented by 218,974 ADSs); and (ii) 1,320,736 Ordinary Shares underlying 165,092 ADSs.
/s/ Claire Poll, Attorney-in-fact for Kathleen A. Rickard
2023-10-24